Page last updated: 2024-08-25

rosiglitazone and Friedreich Disease

rosiglitazone has been researched along with Friedreich Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acquaviva, F; Castaldo, I; Cocozza, S; Filla, A; Marmolino, D; Monticelli, A; Pinelli, M	1

Other Studies

1 other study(ies) available for rosiglitazone and Friedreich Disease

Article	Year
PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy. Cerebellum (London, England), 2009, Volume: 8, Issue:2 Topics: Cell Line, Tumor; Cells, Cultured; Cerebellum; Fibroblasts; Frataxin; Friedreich Ataxia; Humans; Hypoglycemic Agents; Iron-Binding Proteins; Phosphorylcholine; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Up-Regulation	2009

Article

Year

PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.

Cerebellum (London, England), 2009, Volume: 8, Issue:2

Topics: Cell Line, Tumor; Cells, Cultured; Cerebellum; Fibroblasts; Frataxin; Friedreich Ataxia; Humans; Hypoglycemic Agents; Iron-Binding Proteins; Phosphorylcholine; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Up-Regulation

2009